Safety study of GM142 in patients scheduled to undergo surgery for benign gynecologic disease -Multicenter, open study
- Conditions
- Patients scheduled to undergo surgery for benign gynecologic disease
- Registration Number
- JPRN-UMIN000034734
- Lead Sponsor
- GUNZE LIMITED
- Brief Summary
https://doi.org/10.1111/jog.15527
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 34
Not provided
(Preoperative criteria) 1. Patients who have a history of surgery in peritoneal cavity, except operation for appendicitis 2. Patients who had or have active pelvic inflammatory disease or peritonitis 3. Patients who are subject to emergency operation 4. Patients who have gelatin hypersensitivity 5. Patients who have a history of severe drug allergy 6. Patients who are severe diabetes or anomaly of saccharometabolism 7. Patients who are suspected of endometriosis of r-ASRM stage III (Moderate) or greater 8. Patients who require chronic treatment with corticosteroids 9. Patients who are scheduled to undergo radiotherapy or chemoradiotherapy during preoperative and postoperative periods 10. Patients who are scheduled to undergo chemotherapy within 2 weeks after surgery 11. Patients who are administered unapproved medications or medical devices within 12 weeks prior to obtaining the informed consent 12. Patients who are pregnant or lactating, or want to become pregnant during the clinical trial 13. Patients who are undergoing dialysis due to hepatic cirrhosis, active hepatitis, or chronic renal failure 14. Patients who are positive for any infection inappropriate for inclusion in the study based on the judgment of the principal investigator or sub-investigators 15. Patients who have psychiatric disease or symptom for which the enrollment in the study is judged unsuitable 16. Any other patients regarded unsuitable by the principal investigator or sub-investigators (Preoperative criteria: In case of laparoscopic myomectomy) 17. Patients whose largest uterine fibroid has been found to be 10 cm or longer in length in preoperative MRI 18. Patients who have been found to have 10 or more uterine fibroids of 1 cm or larger in diameter in preoperative MRI (Perioperative / Discontinuance criteria) 19. Patients who have been found to have endometriosis of r-ASRM score 16 points or over 20. Patients who have not applied GM142
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events within 12 weeks after surgery
- Secondary Outcome Measures
Name Time Method